Scientific basis for the combination of tegafur with uracil

ONCOLOGY

Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 14-21

  Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; UFT;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG DEGRADATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; STOMACH ABSORPTION;

CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; URACIL;

EID: 0030833056     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Toide H, Akiyoshi H, Minato Y, et al: Comparative studies on the metabolism of I-(2-tetrahydrofuryl)-5-fluorouraciI and 5-fluorouracil. Gann 68:553-560, 1977.
2. Fujii S, Ikenaka K, Fukushima M, et al: Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and l-(2-tetrahydrofuryl)-5-fluorouraciI. Gann 69:763-772, 1978.
3. Fujii S, Kitano S, Ikenaka K, et al: Effect of coadministration of uracil or cytosine on the antitumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-f1uorouracil and level of 5-fluorouracil in rodents. Gann 70:209-214,1979.
4. Fujii S, Kitano S, Ikenaka K, et al: Coadministration of thymidine or thymine on antitumor activity of FT-207 or 5-fluorouracil (in Japanese). Jpn J Cancer Chemother 6:1097-1103, 1979.